Comparison Overview

PCI not the big company

VS

Pharma Intelligence, now Citeline

PCI not the big company

4835 LBJ Fwy, Dallas, TX, 75244, US
Last Update: 2025-11-22
View Profile
Between 750 and 799
http://www.publishingconcepts.com

One of the most stable and well-established companies in the Metroplex, PCI is proud to be voted the #1 Midsize Place to Work for 2015 in both The Dallas Morning News and Texas Monthly! For more than 30 years, Publishing Concepts (PCI) has published alumni directories for top-tier colleges and universities, including Harvard, Princeton, and Texas A&M. At PCI, we are passionate about helping our college, university, and association clients engage their alumni and membership and raise money so that they can fulfill their mission of educating our nation’s future leaders. We partner with our clients to collect massive amounts of data from their alumni / membership, publish alumni and membership directories, create and manage dynamic online communities, and implement innovative fundraising programs. PCI utilizes technology, expertise, best practices, and proven products and services to help colleges, universities, independent schools, fraternities, sororities, and associations of all types drive engagement and maximize contributions. PCI's culture is based on exceptional company values: People, Excellence, Integrity, Profitability, Service, Change, and FUN!

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 168
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Pharma Intelligence, now Citeline

240 Blackfriars Road, London, England SE1 8BF, GB
Last Update: 2025-11-27
Between 750 and 799
https://pharmaintelligence.informa.com

We have a new page! Follow "Citeline, formerly Pharma Intelligence" to stay up to date on all our new posts moving forward as we transition! From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management – you need to make smart decisions that give you an advantage in a fast changing market. The pharma and healthcare sector is facing unparalleled upheaval: increasing pressures on research and development teams to show a better return on investment, difficulty keeping abreast of complex regulatory and pricing and reimbursement environments and the race to get the best deal in a competitive business development arena. Informa’s Pharma Intelligence is the trusted partner of all of the top 50 global pharmaceutical companies and the top 10 contract research organisations (CRO’s) – providing timely intelligence and insight to make authoritative decisions. Our connected team of journalists, researchers and analysts are based in key markets around the globe. Drawing on a foundation of high quality proprietary data you can trust that the insights gained through our solutions have the level of precision needed to make forward focused decisions with confidence.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 0
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/pci-the-data-company.jpeg
PCI not the big company
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/defaultcompany.jpeg
Pharma Intelligence, now Citeline
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
PCI not the big company
100%
Compliance Rate
0/4 Standards Verified
Pharma Intelligence, now Citeline
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for PCI not the big company in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Pharma Intelligence, now Citeline in 2025.

Incident History — PCI not the big company (X = Date, Y = Severity)

PCI not the big company cyber incidents detection timeline including parent company and subsidiaries

Incident History — Pharma Intelligence, now Citeline (X = Date, Y = Severity)

Pharma Intelligence, now Citeline cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/pci-the-data-company.jpeg
PCI not the big company
Incidents

No Incident

https://images.rankiteo.com/companyimages/defaultcompany.jpeg
Pharma Intelligence, now Citeline
Incidents

No Incident

FAQ

Pharma Intelligence, now Citeline company demonstrates a stronger AI Cybersecurity Score compared to PCI not the big company company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Pharma Intelligence, now Citeline company has disclosed a higher number of cyber incidents compared to PCI not the big company company.

In the current year, Pharma Intelligence, now Citeline company and PCI not the big company company have not reported any cyber incidents.

Neither Pharma Intelligence, now Citeline company nor PCI not the big company company has reported experiencing a ransomware attack publicly.

Neither Pharma Intelligence, now Citeline company nor PCI not the big company company has reported experiencing a data breach publicly.

Neither Pharma Intelligence, now Citeline company nor PCI not the big company company has reported experiencing targeted cyberattacks publicly.

Neither PCI not the big company company nor Pharma Intelligence, now Citeline company has reported experiencing or disclosing vulnerabilities publicly.

Neither PCI not the big company nor Pharma Intelligence, now Citeline holds any compliance certifications.

Neither company holds any compliance certifications.

Pharma Intelligence, now Citeline company has more subsidiaries worldwide compared to PCI not the big company company.

PCI not the big company company employs more people globally than Pharma Intelligence, now Citeline company, reflecting its scale as a Book and Periodical Publishing.

Neither PCI not the big company nor Pharma Intelligence, now Citeline holds SOC 2 Type 1 certification.

Neither PCI not the big company nor Pharma Intelligence, now Citeline holds SOC 2 Type 2 certification.

Neither PCI not the big company nor Pharma Intelligence, now Citeline holds ISO 27001 certification.

Neither PCI not the big company nor Pharma Intelligence, now Citeline holds PCI DSS certification.

Neither PCI not the big company nor Pharma Intelligence, now Citeline holds HIPAA certification.

Neither PCI not the big company nor Pharma Intelligence, now Citeline holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
References
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References
Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References